Form 8-K - Current report:
SEC Accession No. 0001493152-24-042600
Filing Date
2024-10-28
Accepted
2024-10-28 07:00:38
Documents
14
Period of Report
2024-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46989
  Complete submission text file 0001493152-24-042600.txt   276222

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20241025.xsd EX-101.SCH 3944
3 XBRL DEFINITION FILE hrow-20241025_def.xml EX-101.DEF 30369
4 XBRL LABEL FILE hrow-20241025_lab.xml EX-101.LAB 37183
5 XBRL PRESENTATION FILE hrow-20241025_pre.xml EX-101.PRE 27388
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6655
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 241398415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)